First Time Loading...

ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 8.56 USD -3.28% Market Closed
Updated: Mar 28, 2024

ESSA Pharma Inc
Operating Income

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ESSA Pharma Inc
Operating Income Peer Comparison

Comparables:
ZYME
TH
RPTX
AUPH
EDT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ESSA Pharma Inc
NASDAQ:EPIX
Operating Income
$-31.9m
CAGR 3-Years
-7%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Operating Income
$-138.1m
CAGR 3-Years
10%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Operating Income
$-19m
CAGR 3-Years
0%
CAGR 5-Years
-28%
CAGR 10-Years
-15%
Repare Therapeutics Inc
NASDAQ:RPTX
Operating Income
$-116.2m
CAGR 3-Years
-30%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Operating Income
$-91.7m
CAGR 3-Years
4%
CAGR 5-Years
-10%
CAGR 10-Years
-36%
Spectral Medical Inc
TSX:EDT
Operating Income
CA$-8.2m
CAGR 3-Years
1%
CAGR 5-Years
-16%
CAGR 10-Years
2%

See Also

What is ESSA Pharma Inc's Operating Income?
Operating Income
-31.9m USD

Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Operating Income amounts to -31.9m USD.

What is ESSA Pharma Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-23%

Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for ESSA Pharma Inc have been -7% over the past three years , -23% over the past five years .